Literature DB >> 27097351

Emerging Mumps Infection.

Steven Rubin1, Richard Kennedy, Gregory Poland.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27097351     DOI： 10.1097/INF.0000000000001182

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  14 in total

1.  Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Authors:  Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

2.  Differential durability of immune responses to measles and mumps following MMR vaccination.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Antonia Thomas; Beth R Larrabee; Steven Rubin; Gregory A Poland
Journal:  Vaccine       Date:  2019-02-20       Impact factor: 3.641

3.  Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.

Authors:  Marguerite M Riggenbach; Iana H Haralambieva; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland; Richard B Kennedy
Journal:  Clin Immunol       Date:  2021-12-28       Impact factor: 3.969

4.  Novel mumps virus epitopes reveal robust cytotoxic T cell responses after natural infection but not after vaccination.

Authors:  Patricia Kaaijk; Maarten E Emmelot; Hugo D Meiring; Cécile A C M van Els; Jelle de Wit
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

5.  Mumps Outbreak in a Highly Vaccinated University-Affiliated Setting Before and After a Measles-Mumps-Rubella Vaccination Campaign-Iowa, July 2015-May 2016.

Authors:  Minesh Shah; Patricia Quinlisk; Andrew Weigel; Jacob Riley; Lisa James; James Patterson; Carole Hickman; Paul A Rota; Rebekah Stewart; Nakia Clemmons; Nicholas Kalas; Cristina Cardemil
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

6.  Assessing the Changes of Mumps Characteristics with Different Vaccination Strategies Using Surveillance Data: Importance to Introduce the 2-Dose Schedule in Quzhou of China.

Authors:  Chunting Zhou; Wei Song; Zhiying Yin; Sheng Li; Xiaoying Gong; Quanjun Fang; Shuangqing Wang
Journal:  J Immunol Res       Date:  2020-03-27       Impact factor: 4.818

Review 7.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

8.  Forecasting the incidence of mumps in Chongqing based on a SARIMA model.

Authors:  Hongfang Qiu; Han Zhao; Haiyan Xiang; Rong Ou; Jing Yi; Ling Hu; Hua Zhu; Mengliang Ye
Journal:  BMC Public Health       Date:  2021-02-17       Impact factor: 3.295

9.  Genetic Analysis Reveals Differences in CD8+ T Cell Epitope Regions That May Impact Cross-Reactivity of Vaccine-Induced T Cells against Wild-Type Mumps Viruses.

Authors:  Patricia Kaaijk; Maarten E Emmelot; Jeroen Kerkhof; Cécile A C M van Els; Hugo D Meiring; Jelle de Wit; Rogier Bodewes
Journal:  Vaccines (Basel)       Date:  2021-06-25

10.  Association between ozone exposure and prevalence of mumps: a time-series study in a Megacity of Southwest China.

Authors:  Wenjun Xie; Han Zhao; Chang Shu; Bin Wang; Wen Zeng; Yu Zhan
Journal:  Environ Sci Pollut Res Int       Date:  2021-07-27       Impact factor: 4.223
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.